Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Issuance of Common Stock

Adverum Biotechnlgs Issuance of Common Stock Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Issuance of Common Stock from 2014 to 2020.
  • Adverum Biotechnlgs Issuance of Common Stock for the quarter ending June 06, 2020 was $3m a 94.90% increase of 3m year over year
  • Adverum Biotechnlgs Issuance of Common Stock for the last 12 months ending June 06, 2020 was $180m a 98.28% increase of 177m year over year
  • Adverum Biotechnlgs Annual Issuance of Common Stock for 2019 was $30m a -139.19% decrease of -41m from 2018
  • Adverum Biotechnlgs Annual Issuance of Common Stock for 2018 was $71m a 76.04% increase of 54m from 2017
  • Adverum Biotechnlgs Annual Issuance of Common Stock for 2017 was $17m a 94.44% increase of 16m from 2016
Other Cash Flow Metrics:
  • Adverum Biotechnlgs Cash Flow from Operations for the quarter ending December 12, 2018 was $-13m a -2.00% increase of 0m year over year
  • Adverum Biotechnlgs Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-26m a 70.14% decrease of -18m year over year
  • Adverum Biotechnlgs Total Revenue for the quarter ending September 09, 2018 was $1m a 44.66% increase of 0m year over year
View Chart On Koyfin

Quarterly ADVM Issuance of Common Stock Data

06/2020$3m
03/2020$151m
12/2019$27m
09/2019$0m
06/2019$3m
03/2019$0m
12/2018$0m
09/2018$0m
06/2018$0m
03/2018$70m

Annual ADVM Issuance of Common Stock Data

2019$30m
2018$71m
2017$17m
2016$1m
2015$139m
2014$117m